IL5 and neoplasm: IL-5 is a well-known Th2 cytokine (Koyasu and Moro 2011) and Th2 immunity has been shown to favour tumour growth via promoting angiogenesis and inhibiting anti-tumour immunity (Ellyard et al. 2007).